Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Bond Issue

11 Jun 2025 09:37

RNS Number : 3871M
Experian plc
11 June 2025
Β 

Β 

Experian plc

Β 

Β 

Bond Issue

Β 

Β 

11 June 2025 - Experian plc, the global data and technology company, announces that its subsidiary, Experian Finance plc, rated A3 / A-, has priced an issue of $500million 5.250% bonds due 17 August 2035 (the "Notes"). The Notes will be issued by Experian Finance plc and guaranteed byΒ Experian plc.

Β 

This bond issue extends the maturity of the Group's debt portfolio and diversifies its funding sources. The net proceeds of the offering will be used for general corporate purposes, including potential acquisitions and the repayment of debt. The issue is scheduled to close on 17 June 2025, subject to customary conditions.

Β 

It is expected that the Notes will be admitted to the official list of Euronext Dublin and admitted to trading on the Global Exchange Market.

Β 

The Notes are being sold to qualified institutional buyers in the United States in accordance with Rule 144A under the US Securities Act of 1933Β ("Securities Act"), and to non-US persons outside the United States in reliance upon Regulation S under the Securities Act. The Notes and the guarantee have not been, and will not be, registered under the Securities Act, or the securities laws of any state of the United States or other jurisdiction, and may not be offered or sold in the United Sates, or to, or for the account or benefit of, US persons, other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Β 

This announcement does not constitute or form part of any offer or any solicitation to purchase nor shall it, or the fact of its distribution, form the basis of, or be relied on in any purchase. The distribution of this announcement and any subsequent offer of securities may be restricted by law in certain jurisdictions and persons receiving this announcement or any subsequent offer should inform themselves about and observe any such restriction. Failure to comply with such restrictions may violate securities laws of any such jurisdiction.

Β 

Β 

Contact:

Β 

Experian

Remco de Vries Group Treasurer +353 (0) 86 380 2791

Lorraine Keogh Deputy Group Treasurer +353 (0) 86 380 2193

Β 

Β 

About Experian

Β 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

Β 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Β 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IODSFISAFEISEDM
Date   Source Headline
14th May 202510:42 amRNSAdditional Listing
14th May 20257:24 amRNSFull-year financial report
30th Apr 202510:43 amRNSTotal Voting Rights
30th Apr 20259:30 amRNSAdditional Listing
16th Apr 20259:54 amRNSAdditional Listing
9th Apr 20259:21 amRNSAdditional Listing
2nd Apr 20259:42 amRNSAdditional Listing
2nd Apr 20257:00 amRNSEXPERIAN COMPLETES ACQUISITION OF CLEARSALE
31st Mar 202512:15 pmRNSTotal Voting Rights
26th Mar 20259:40 amRNSAdditional Listing
21st Mar 20255:22 pmRNSTransaction in Own Shares
20th Mar 20259:32 amRNSAdditional Listing
18th Mar 202511:22 amRNSBlock listing Interim Review
14th Mar 20255:20 pmRNSTransaction in Own Shares
13th Mar 20255:38 pmRNSDirector/PDMR Shareholding
13th Mar 20255:29 pmRNSTransaction in Own Shares
12th Mar 20255:04 pmRNSTransaction in Own Shares
11th Mar 20255:28 pmRNSTransaction in Own Shares
10th Mar 20255:25 pmRNSTransaction in Own Shares
28th Feb 20255:29 pmRNSTransaction in Own Shares
28th Feb 20253:16 pmRNSTotal Voting Rights
27th Feb 20255:29 pmRNSTransaction in Own Shares
26th Feb 20255:39 pmRNSTransaction in Own Shares
25th Feb 20255:34 pmRNSTransaction in Own Shares
24th Feb 20255:37 pmRNSTransaction in Own Shares
21st Feb 20255:36 pmRNSTransaction in Own Shares
20th Feb 20255:46 pmRNSTransaction in Own Shares
19th Feb 20255:17 pmRNSTransaction in Own Shares
18th Feb 20255:45 pmRNSTransaction in Own Shares
12th Feb 20257:00 amRNSDirectorate Change
10th Feb 20254:08 pmRNSDirector/PDMR Shareholding
31st Jan 202511:41 amRNSTotal Voting Rights
24th Jan 202510:25 amRNSOutcome of audit tender process
17th Jan 20255:14 pmRNSFirst interim dividend
16th Jan 20255:14 pmRNSBond Issue
15th Jan 20257:00 amRNSExperian Q3 FY25 trading update
31st Dec 202410:16 amRNSTotal Voting Rights
23rd Dec 20241:39 pmRNSShare repurchase programme
20th Dec 20249:00 amRNSElections for first interim dividend
12th Dec 20249:25 amRNSDirector Declaration
29th Nov 20243:56 pmRNSTotal Voting Rights
13th Nov 20247:00 amRNSHalf-year Report
5th Nov 20241:51 pmRNSTotal Voting Rights - Amendment
31st Oct 202412:19 pmRNSTotal Voting Rights
4th Oct 202412:44 pmRNSExperian to acquire Clearsale in Brazil
30th Sep 202412:30 pmRNSTotal Voting Rights
30th Sep 20248:29 amRNSExperian Completes Acquisition of Ilion
16th Sep 202412:10 pmRNSBlock listing Interim Review
4th Sep 20243:30 pmRNSBond Issue
30th Aug 20243:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.